Impact of Atorvastatin on Prostate Cancer Progression During ADT

NCT04026230 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Cancer
Recurrent Prostate Cancer

Interventions

DRUG: Atorvastatin 80mg
DRUG: Placebo oral capsule

Sponsor

Tampere University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]